Slideshow

February 14, 2020

8 Considerations in the Differential Diagnosis of Posttraumatic Psychosis

Author(s):

Lindsey Gurin, MD,David B. Arciniegas, MD

Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.

Related Content

April 22nd 2025

Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial

Leah Kuntz

September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD

April 15th 2025

The Slow Road to Psychosis

Hussein Hijazi, MD Nidal Moukaddam, MD, PhD

July 23rd 2021

What Will the Future of Alzheimer Disease Treatment Look Like?

Helen Lavretsky, MD, MS

April 11th 2025

Examining a Case of Acute Late-Pregnancy Psychosis: How Best to Coordinate Care

Cecilia A. Westbrook, MD, PhD Meredith Spada, MD Elizabeth M. Hovis, MD Jacob Larkin, MD Alexandra Nicholas, MD Luke Swider, MD Jonathan Yadlosky, MD Joseph S. DeRenzo, MD Adam P. Dunmore, MD Jennifer L. Kloesz, MD, FAAP Linda Dudas, RNC, MSN, CNL John Silipigni, MSW, MBA Priya Gopalan, MD

April 7th 2025

Online Survey Reveals Clinicians’ Top Concerns in BDI, Schizophrenia Treatment

Grace Koennecke